LALPATHLAB.NS Overview

Company Profile

Related stocks

SAILIFE.NS • India

SAI LIFE SCIENCES LIMITED

1,487.9 INR

3.27B USD 1Y +74.7%

SYNGENE.NS • India

SYNGENE INTERNATIONAL LTD

347.4 INR

1.44B USD 1Y -45.1%

VIJAYA.NS • India

VIJAYA DIAGNOSTIC CEN LTD

1,436.6 INR

1.53B USD 1Y +44.5%

METROPOLIS.NS • India

METROPOLIS HEALTHCARE LTD

529.25 INR

1.13B USD 1Y +4.2%

3347.HK • China

TIGERMED

44.56 HKD

4.89B USD 1Y +3.2%

603882.SS • China

GUANGZHOU KINGMED DIAGNOSTICS G

28.82 CNY

2B USD 1Y -3.4%

THYROCARE.BO • India

Thyrocare Technologies Limited

499 INR

820.66M USD 1Y +22%

300676.SZ • China

BGI GENOMICS

45.47 CNY

2.85B USD 1Y -9.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Diagnostics & Research

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

31.6% p.a.

Max Drawdown (5Y)

-54.2%

Sharpe Ratio (5Y)

-0.06

Beta Factor

0.16

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 59.7 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.6% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -57.7% in the extended horizon.